神田　敦宏　業績集

英文業績（２００３年から現在まで）

IF (impact factor)：　2018年ISI Journal Citation Reportsより

 

本数

ＩＦ合計

一編あたり

First author

24

94.873

3.953

Corresponding author

11

42.751

3.886

Second author

2

6.844

3.422

その他

2

7.940

3.970

英文全業績

49

145.392

2.967

 

86

289.860

3.370

英文著書

  1. Kanda A, Ishida S. Roles of the retinal pigment epithelium in neuroprotection.　 Neuroprotection and Regeneration for Retinal Diseases. eds: Nakazawa, T. and Harada T, Springer. 2014; 227-238
  2. Kawada T, Sekiguchi T, Sugase K, Kanda A, Satake H. Evolutionary Aspects of Molecular Forms and Biological Functions of Oxytocin Family Peptides. Handbook of Oxytocin Research: Synthesis, Storage and Release, Actions, and Drug Forms. Jastrow H. and Feuerbach D. (Eds.), 59-86. Nova Science Publishers, Inc., NY. 2009
  3. Hori T, Kanda A and Ito F. Progress in molecular mechanism of neurodegeneration in Parkinson’s disease. (Degeneration and regeneration in neurons. Research Signpost, Trivandrum, India) p.93-107. 2006

英文原著

(● corresponding author)

    1. Hase K, Namba K, Wada H, Tsuji H, Maeda A, Murata T, Otsuka R, Iwata D, Kanda A, Noda K, Kitaichi N, Seino K, Ishida S. Macrophage-like iPS-derived suppressor cells reduce Th1-mediated immune response to a retinal antigen. Curr Eye Res. Epub ahead of print
    2. Hashimoto Y, Saito W, Kanaizumi S, Saito M, Noda K, Kanda A, Ishida S. Comparison of clinical characteristics in patients with acute zonal occult outer retinopathy according to anti-retinal antibody status. Graefes Arch Clin Exp Ophthalmol. 2021; 259: 2967-2976
    3. Hase K, Kase S, Kanda A, Shinmei Y, Noda K, Ishida S. Expression of vascular endothelial growth factor-C in the trabecular meshwork of patients with neovascular glaucoma and primary open-angle glaucoma. J Clin Med. 2021; 10: 2977
    4. Hirakata T, Fujinami K, Saito W, Kanda A, Hirakata A, Ishida S, Murakami A, Tsunoda K, Miyake Y. Acute Unilateral Inner Retinal Dysfunction with Photophobia - Importance of Electrodiagnosis -. Jpn J Ophthalmol. 2021; 65: 42-53
    5. Yamamoto T, *Kanda A, Kase S, Ishida S. Hypoxia induces galectin-1 expression via autoinduction of placental growth factor in retinal pigment epithelium cells. Invest Ophthalmol Vis Sci. 2021; 62: 22
    6. Ishizuka ET, *Kanda A, Shinmei Y, Ohguchi T, Tagawa Y, Hase K, Yamamoto T, Noda K, Chin S, Ishida S. Receptor-Associated Prorenin System in the Trabecular Meshwork of Patients with Primary Open-Angle Glaucoma and Neovascular Glaucoma. J Clin Med. 2020; 9: E2336
    7. Jiang K, Fairless E, Kanda A, Gotoh N, Cogliati T, Li T, Swaroop A. Divergent effects of HSP70 overexpression in photoreceptors during inherited retinal degeneration. Invest Ophthalmol Vis Sci. 2020; 61: 25
    8. ● Kanda A, Hirose I, Noda K, Murata M, Ishida S. Glucocorticoid-transactivated TSC22D3 attenuates hypoxia- and diabetes-induced Müller glial galectin-1 expression via HIF-1α destabilization. J Cell Mol Med. 2020; 24: 4589-4599
    9. Kikuchi K, Dong Z, Shinmei Y, Murata M, Kanda A, Noda K, Harada T, Ishida S. Cytoprotective effect of astaxanthin in a model of normal intraocular pressure glaucoma. J Ophthalmol. 2020; 2020: 9539681
    10. Liu Y, Kitaichi N, Wu D, Hase K, Satoh M, Iwata D, Namba K, Kanda A, Noda K, Itai A, Iwabuchi K, Ishida S. Attenuation of experimental autoimmune uveoretinitis in mice by IKKβ inhibitor IMD-0354. Biochem Biophys Res Commun. 2020; 525: 589-594
    11. Liu Y, Noda K, Murata M, Wu D, Kanda A, Ishida S. Blockade of Platelet-Derived Growth Factor Signaling Inhibits Choroidal Neovascularization and Subretinal Fibrosis in Mice. J Clin Med. 2020; 9: E2242
    12. Miura G, Baba T, Iwase T, Ohde H, Kanda A, Saito W, Ishida S, Yamamoto S. Non-paraneoplastic autoimmune retinopathy that developed in fellow eye 10 years after onset in first eye: a case report. BMC Ophthalmol. 2020; 20: 132
    13. Wu D, Noda K, Murata M, Liu Y, Kanda A, Ishida S. Regulation of Spermine Oxidase through Hypoxia-inducible Factor-1α Signaling in Retinal Glial Cells under Hypoxic Conditions. Invest Ophthalmol Vis Sci. 2020; 61: 52
    14. Wu D, ●Kanda A, Liu Y, Noda K, Murata M, Ishida S. Involvement of Müller glial autoinduction of transforming growth factor-β in diabetic fibrovascular proliferation via glial-mesenchymal transition. Invest Ophthalmol Vis Sci. 2020; 61: 29
    15. Hase K, ●Kanda A, Noda K, Ishida S. Increased plasma galectin-1 correlates with advanced glycation end products and interleukin-1β in patients with proliferative diabetic retinopathy. Int J Ophthalmol.2019; 12: 692-694
    16. Hashimoto Y, Saito W, Namba K, Mizuuchi K, Iwata D, Noda K, Kanda A, Ishida S. Comparison of clinical characteristics in patients with Vogt-Koyanagi-Harada disease with and without anti-retinal antibodies. Graefes Arch Clin Exp Ophthalmol. 2019; 257: 1751-1758
    17. Hirose I, ● Kanda A, Noda K, Ishida S. Glucocorticoid receptor inhibits Müller glial galectin-1 expression via DUSP1-dependent and -independent deactivation of AP-1 signalling. J Cell Mol Med. 2019; 23: 6785-6796
    18. Kanda A, Ishida S. (Pro)renin receptor: Involvement in diabetic retinopathy and development of molecular targeted therapy. J Diabetes Investig. 2019; 10: 6-17
    19. Kanda A, Noda K, Hirose I, Ishida S. TGF-β-SNAIL axis induces Müller glial-mesenchymal transition in the pathogenesis of idiopathic epiretinal membrane. Sci Rep. 2019; 9: 673
    20. Liu Y, ● Kanda A, Wu D, Ishizuka ET, Kase S, Noda K, Ichihara A, Ishida S. Suppression of choroidal neovascularization and fibrosis by a novel RNAi therapeutic agent against (pro)renin receptor. Mol Ther Nucleic Acids.2019: 17: 113-125
    21. Murata M, Noda K, Yoshida S, Saito M, Fujiya A, Kanda A, Ishida S. Unsaturated Aldehyde Acrolein Promotes Retinal Glial Cell Migration. Invest Ophthalmol Vis Sci. 2019; 60: 4425-4435
    22. Wu D, ● Kanda A, Liu Y, Kase S, Noda K, Ishida S. Galectin-1 promotes choroidal neovascularization and subretinal fibrosis mediated via epithelial-mesenchymal transition. FASEB J. 2019; 33: 2498-2513
    23. Ando R, Saito W, Kanda A, Kase S, Fujinami K, Sugahara M, Nakamura Y, Eguchi S, Mori S, Noda K, Shinoda K, Ishida S.Clinical features of Japanese patients with anti-α-enolase antibody-positive autoimmune retinopathy: Novel subtype of multiple drusen. Am J Ophthalmol. 2018; 196: 181-196
    24. Yoshida S, Murata M, Noda K, Matsuda T, Saito M, Saito W, Kanda A, Ishida S. Proteolytic cleavage of vascular adhesion protein-1 induced by vascular endothelial growth factor in retinal capillary endothelial cells. Jpn J Ophthalmol. 2018; 62: 256-264
    25. Dong Y, ● Kanda A, Noda K, Saito W, Ishida S. Pathologic roles of receptor-associated prorenin system in idiopathic epiretinal membrane. Sci Rep. 2017; 7: 44266
    26. Dong Y, Noda K, Murata M, Yoshida S, Saito W, Kanda A, Ishida S. Localization of acrolein-lysine adduct in fibrovascular tissues of proliferative diabetic retinopathy. Curr Eye Res. 2017; 42: 111-117
    27. Hase K, ● Kanda A, Hirose I, Noda K, Ishida S. Systemic factors related to soluble (pro)renin receptor in plasma of patients with proliferative diabetic retinopathy. PLoS ONE. 2017; 12: e0189696
    28. ● Kanda A, Dong Y, Noda K, Saito W, Ishida S. Advanced glycation endproducts link inflammatory cues to upregulation of galectin-1 in diabetic retinopathy. Sci Rep. 2017；7：16168
    29. ● Kanda A, Ishizuka ET, Shibata A, Matsumoto T, Toyofuku H, Noda K, Namba K, Ishida S. A novel single-strand RNAi therapeutic agent targeting (pro)renin receptor suppresses ocular inflammation. Mol Ther Nucleic Acids. 2017; 7: 116-126
    30. Kinoshita S, Ohguchi T, Noda K, Murata M, Yasueda S, Obata H, Matsunaga T, Fukushima T, Kanda A, Ishida S. Evaluation of the safety and tolerability of conjunctival ring for posterior segment of the eye. Curr Eye Res. 2017; 30: 1-6
    31. Matsuda T, Noda K, Murata M, Kawasaki A, Kanda A, Mashima Y, Ishida S. Vascular Adhesion Protein-1 Blockade Suppresses Ocular Inflammation after Retinal Laser Photocoagulation in Mice. Invest Ophthalmol Vis Sci. 2017; 58: 3254-3261
    32. Murata M, Noda K, Kawasaki A, Yoshida S, Dong Y, Saito M, Dong Z, Ando R, Mori S, Saito W, Kanda A, Ishida S. Soluble vascular adhesion protein-1 mediates spermine oxidation as semicarbazide-sensitive amine oxidase: possible role in proliferative diabetic retinopathy. Curr Eye Res. 2017; 42: 1674-1683
    33. Suimon Y, Saito W, Hirooka K, Kanda A, Kitai H, Sakakibara-Konishi J, Ishida S. Improvements of visual function and outer retinal morphology following spontaneous regression of cancer in anti-recoverin cancer-associated retinopathy. Am J Ophthalmol Case Rep. 2017; 5: 137-140
    34. Dong Y, Dong Z, Kase S, Ando R, Fukuhara J, Kinoshita S, Inafuku S, Tagawa Y, Ishizuka ET, Saito W, Murata M, Kanda A, Noda K, Ishida S. Phosphorylation of alphaB-crystallin in epiretinal membrane of human proliferative diabetic retinopathy. Int J Ophthalmol. 2016; 9: 1100-1105
    35. Dong Y, Kase S, Dong Z, Fukuhara J, Tagawa Y, Ishizuka ET, Murata M, Shinmei Y, Ohguchi T, Kanda A, Noda K, Ishida S. Regulation of vascular endothelial growth factor-C by tumor necrosis factor-α in the conjunctiva and pterygium. Int J Mol Med. 2016; 38: 545-550
    36. Dong Z, Shinmei Y, Dong Y, Inafuku S, Fukuhara J, Ando R, Kitaichi N, Kanda A, Tanaka K, Noda K, Harada T, Chin S, Ishida S. Effect of geranylgeranylacetone on the protection of retinal ganglion cells in a mouse model of normal tension glaucoma. Heliyon. 2016; 2: e00191
    37. ● Kanda A, Ishida S. Receptor-associated prorenin system contributes to development of inflammation and angiogenesis in proliferative diabetic retinopathy. Inflamm Regen. 2016; 36: 22
    38. Kinoshita S, Noda K, Saito W, Kanda A, Ishida S. Vitreous levels of vascular endothelial growth factor-B in proliferative diabetic retinopathy. Acta Ophthalmol. 2016; 94: e521-523
    39. Inafuku S, Noda K, Amano M, Ohashi T, Yoshizawa C, Saito W, Kanda A, Nishimura S, Ishida S. Alteration of N-glycan profiles in diabetic retinopathy. Invest Ophthalmol Vis Sci. 2015; 56: 5316-5322
    40. ● Kanda A, Noda K, Saito W, Ishida S. Aflibercept traps galectin-1, an angiogenic factor associated with diabetic retinopathy. Sci Rep. 5: 17946, 2015
    41. Kitai H, Sakakibara-Konishi J, Oizumi S, Hirohashi Y, Saito W, Kanda A, Sato N, Nishimura M. Spontaneous regression of small cell lung cancer combined with cancer associated retinopathy. Lung Cancer. 2015; 87: 73-76
    42. Kanda A, Noda K, Ishida S. ATP6AP2/(pro)renin receptor contributes to glucose metabolism via stabilizing the pyruvate dehydrogenase E1 ß subunit. J Biol Chem. 290:9690-9700, 2015
    43. Ishizuka ET, ●Kanda A, Kase S, Noda K, Ishida S. Involvement of the Receptor-Associated Prorenin System in the Pathogenesis of Human Conjunctival Lymphoma. Invest Ophthalmol Vis Sci. 2014; 56:74-80
    44. Ando R, Noda K, Namba S, Saito W, Kanda A, Ishida S. Aqueous humor levels of placental growth factor in diabetic retinopathy. Acta Ophthalmol. 2014; 92: 245-6
    45. Ando R, Noda K, Tomaru U, Kamoshita M, Ozawa Y, Notomi S, Hisatomi T, Noda M, Kanda A, Ishibashi T, Kasahara M, Ishida S. Decreased Proteasomal Activity Causes Photoreceptor Degeneration in Mice. Invest Ophthalmol Vis Sci. 2014; 55: 4682-4690
    46. Dong Z, Iwata D, Kitaichi N, Takeuchi M, Sato M, Endo N, Iwabuchi K, Ando R, Fukuhara J, Kinoshita S, Lennikov A, Kitamura M, Mizuuchi K, Kanda A, Noda K, Namba K, Yamagishi S, Ohno S, Ishida S. Amelioration of experimental autoimmune uveoretinitis by inhibition of glyceraldehyde derived-advanced glycation end product formation. J Leukoc Biol. 2014; 96: 1077-1085
    47. Inafuku S, Noda K, Amano M, Ohashi, Yoshizawa C, Saito W, Kanda A, Nishimura S, Ishida S. A comparison of N-glycan profiles in human plasma and vitreous fluid. Graefes Arch Clin Exp Ophthalmo 2014; 252: 1235-1243
    48. Kinoshita S, Noda K, Tagawa Y, Inafuku S, Dong Y, Fukuhara J, Dong Z, Ando R, Kanda A, Ishida S. Genistein Attenuates Choroidal Neovascularization. J Nutr Biochem. 2014; 25: 1177-1182
    49. Kinoshita S, Kase S, Ando R, Dong Z, Fukuhara J, Dong Y, Takashina S, Noda K, Noda M, Kanda A, Ishida S. Expression of vascular endothelial growth factor in human ocular adnexal lymphoma. Invest Ophthalmol Vis Sci. 2014; 55: 3461-7
    50. Saito M, Saito W, Kanda A, Ohguro H,Ishida S. A case of paraneoplastic optic neuropathy and outer retinitis positive for autoantibodies against collapsin response mediator protein-5, recoverin, and α-enolase. BMC Ophthalmol. 2014; 14: 5
    51. Yaguchi H, Yabe I, Takahashi H, Okumura F, Takeuchi A, Horiuchi K, Kano T, Kanda A, Saito W, Matsumoto M, Nakayama K, Hatakeyama S, Sasaki H. Identification of anti-Sez6l2 antibody in a patient with cerebellar ataxia and retinopathy. J Neurol. 2014; 261:224-226
    52. Dong Z, Kase S, Ando R, Fukuhara J, Kinoshita S, Dong Y, Takashina S, Kanda A, Noda M, Noda K, Ishida S. Expression of alphaB-crystallin and vascular endothelial growth factor in conjunctival squamous cell carcinoma. Anticancer Res. 2013; 33: 3745-3751
    53. Dong Z, Noda K, Kanda A, Fukuhara J, Ando R, Murata M, Saito W, Hagiwara M, Ishida 　Specific inhibition of serine/arginine-rich protein kinase attenuates choroidal neovascularization. Mol Vis. 2013; 19: 536-543
    54. Kanda A, Ishida S. Vitreous renin-angiotensin system is mediated by soluble (pro)renin receptor in diabetic retinopathy: new implication of receptor-associated prorenin system. Twn J Ophthalmol. 2013; 3:51-53
    55. Fukuhara J, Kase S, Ohashi T, Ando R, Dong Z, Noda K, Ohguchi T, Kanda A, Ishida S. Expression of vascular endothelial growth factor C in human pterygium. Histochem Cell Biol. 2013; 139: 381-389
    56. Kanda A, Noda K, Saito W, Ishida S. Vitreous renin activity correlates with vascular endothelial growth factor in proliferative diabetic retinopathy. Br J Ophthalmol. 2013; 97: 666-668
    57. Kanda A, Noda K, Yuki K, Ozawa Y, Furukawa T, Ichihara A, Ishida S. Atp6ap2/(pro)renin receptor interacts with Par3 as a cell polarity determinant required for laminar formation during retinal development in mice. J Neurosci. 2013; 33: 19341-19351
    58. Fukuhara J, Noda K, Murata M, Namba S, Kinoshita S, Dong Z, Ando R, Lennikov A, Kanda A, Ishida S. Tissue kallikrein attenuates choroidal neovascularization via cleavage of vascular endothelial growth factor. Invest Ophthalmol Vis Sci. 2013; 54: 274-279
    59. Kase S, Rao NA, Yoshikawa H, Fukuhara J, Noda K, Kanda A, Ishida S. Expression of vascular endothelial growth factor in eyes with Coats disease. Invest Ophthalmol Vis Sci. 2013; 54: 57-62
    60. Dong Z, Kase S, Ando R, Fukuhara J, Saito W, Kanda A, Murata M, Noda K, Ishida S. AlphaB-crystallin expression in epiretinal membrane of humanproliferative diabetic retinopathy. 2012; 32: 1190-1196
    61. Fukuhara J, Kase S, Noda K, Kanda A, Murata M, Noda M, Ando R, Dong Z, Ishida S. Immunolocalization of vascular adhesion protein-1 in human conjunctival tumors. Ophthalmic Res. 48: 33-37, 2012
    62. Kanda A, Noda K, Saito W, Ishida S. (Pro)renin receptor is associated with angiogenic activity in proliferative diabetic retinopathy. Diabetologia. 2012; 55: 3104-3113 (Up to front)
    63. Kanda A, Noda K, Oike Y, Ishida S. Angiopoietin-like protein 2 mediates endotoxin-induced acute inflammation in the eye. Lab Invest. 2012; 92:1553-63 (Journal cover)
    64. Murata M, Noda K, Fukuhara J, Kanda A, Kase S, Saito W, Ozawa Y, Mochizuki S, Kimura S, Mashima Y, Okada Y, Ishida S. Soluble vascular adhesion protein-1 accumulates in proliferative diabetic retinopathy. Invest Ophthalmol Vis Sci. 2012; 53: 4055-62
    65. Satofuka S, Kanda A, Ishida S. Receptor-associated prorenin system in the pathogenesis of retinal diseases. Front Biosci. 2012; 4: 1449-1460
    66. Horie Y, Meguro A, Kitaichi N, Lee E B, Kanda A, Noda K, Song Y W, Park K S, Namba K, Ota M, Inoko H, Mizuki N, Ishida S, Ohno S. Replication of a microsatellite genome-wide association study of Behcet disease in a Korean population. Rheumatology. 2012; 51: 983-986
    67. Ando A, Kase S, Ohashi T, Doug Z, Fukuhara J, Kanda A, Murata M, Noda K, Ishida S. Tissue factor expression in human pteryium. Mol Vis. 2011; 17: 63-69
    68. McKay GJ, Patterson CC, Chakravarthy U, Dasari S, Klaver CC, Vingerling JR, Ho L, de Jong PT, Fletcher AE, Young IS, Seland JH, Rahu M, Soubrane G, Tomazzoli L, Topouzis F, Vioque J, Hingorani AD, Sofat R, Dean M, Sawitzke J, Seddon JM, Peter I, Webster AR, Moore AT, Yates JR, Cipriani V, Fritsche LG, Weber BH, Keilhauer CN, Lotery AJ, Ennis S, Klein ML, Francis PJ, Stambolian D, Orlin A, Gorin MB, Weeks DE, Kuo CL, Swaroop A, Othman M, Kanda A, Chen W, Abecasis GR, Wright AF, Hayward C, Baird PN, Guymer RH, Attia J, Thakkinstian A, Silvestri G. Evidence of association of APOEwith age-related macular degeneration - a pooled analysis of 15 studies. Hum Mutat, 32: 1407-1416, 2011
    69. Santon C, Yates J, den Hollander A, Seddon J, Swaroop A, Stambolian D, Fauser, S, Hoyng, C, Kanda A, Branham K, Othman M, Chen W, Kortvely E, Chalmers K, Hayward C, Moore A, Dhillon B, Ueffing M & Wright A. Complement factor d in age-related macular degeneration. Invest Ophthalmol Vis Sci. 2011; 52: 8828-8834
    70. McKay GJ, Silvestri G, Chakravarthy U, Dasari S, Fritsche LG, Weber BH, Keilhauer CN, Klein ML, Francis PJ, Klaver CC, Vingerling JR, Ho L, De Jong PT, Dean M, Sawitzke J, Baird PN, Guymer RH, Stambolian D, Orlin A, Seddon JM, Peter I, Wright AF, Hayward C, Lotery AJ, Ennis S, Gorin MB, Weeks DE, Kuo CL, Hingorani AD, Sofat R, Cipriani V, Swaroop A, Othman M, Kanda A, Chen W, Abecasis GR, Yates JR, Webster AR, Moore AT, Seland JH, Rahu M, Soubrane G, Tomazzoli L, Topouzis F, Vioque J, Young IS, Fletcher AE, Patterson CC. Variations in Apolipoprotein E Frequency With Age in a Pooled Analysis of a Large Group of Older People. Am J Epidemiol. 173:1357-1364, 2011
    71. Kanda A, Stambolian D, Chen W, Curcio CA, Abecasis GR, Swaroop A. Age-related macular degeneration-associated variants at chromosome 10q26 do not significantly alter ARMS2 and HTRA1 transcript levels in human retina. Mol Vis. 2010; 16: 1317-1323
    72. Chen W, Stambolian D, Edwards AO, Branham KE, Othman M, Jakobsdottir J, Tosakulwong N, Pericak-Vance MA, Campochiaro PA, Klein ML, Tan PL, Conley YP, Kanda A, Kopplin L, Li Y, Augustaitis KJ, Karoukis AJ, Scott WK, Agarwal A, Kovach JL, Schwartz SG, Postel EA, Brooks M, Baratz KH, Brown WL, Group CR, Brucker AJ, Orlinn A, Brown G, Ho A, Regillo C, Donoso L, Tian L, Kaderli B, Hadley D, Hagstrom SA, Peachey NS, Klein R, Klein BEK, Gotoh N, Yamashiro K, Ferris F, Fagerness JA, Reynolds R, Farrer LA, Kim IK, Miller JW, Cortón M, Carracedo A, Sanchez-Salorio M, Pugh EW, Doheny KF, Brion M, DeAngelis MM, Week DE, Zack D, Chew EY, Heckenlively JR, Yoshimura N, Iyengar SK, Francish PJ, Katsanis N, Seddon JM, Haines JL, Gorin MB, Abecasis GR, Swaroop A. Genetic Variants near TIMP3 and HDL-Associated Loci Influence Susceptibility to Age-Related Macular Degeneration.　 Natl. Acad. Sci. USA, 107:7401-7406, 2010
    73. ● Kanda A, Swaroop A. A comprehensive analysis of sequence variants and putative disease-causing mutations in photoreceptor-specific nuclear receptor NR2E3.Mol Vis. 2009; 15: 2174-2184
    74. Kanda A, Abecasis GR, Swaroop A. Inflammation in the pathogenesis of age-related macular degeneration. Br J Ophthalmol. 92: 448-450, 2008
    75. Kanda A, Chen W, Othman M, Branham KEH, Brooks M, Khanna R, He S, Lyons R, Abecasis GR, Swaroop A. A variant of mitochondrial protein LOC387715/ARMS2, not HTRA1, is strongly associated with age-related macular degeneration. Natl. Acad. Sci. USA, 104: 16227-16232, 2007
    76. Kanda A, Friedman JS, Nishiguchi KM, Swaroop A. Retinopathy mutations in the bZIP protein NRL alter phosphorylation and transcriptional activity. Hum Mutat, 28: 589-598, 2007
    77. ● Kanda A, Takuwa-Kuroda K, Aoyama M, Satake H. A novel tachykinin-related peptide receptor of Octopus vulgaris-Evolutionary aspects of invertebrate tachykinin and tachykinin-related peptide. FEBS J, 274: 2229-2239, 2007
    78. Kanda A, Takahashi T, Satake H, Minakata H. Molecular and functional characterization of a novel gonadotropin-releasing-hormone receptor isolated from the common octopus (Octopus vulgaris). Biochem J, 395: 125-135, 2006
    79. Kanda A, Minakata H. Isolation and characterization of a novel small cardioactive peptide-related peptide from the brain of Octopus vulgaris. Peptides, 27: 1755-1761, 2006
    80. Kanda A, Satake H, Kawada T, Minakata H. Novel evolutionary lineages of the invertebrate oxytocin/vasopressin superfamily peptides and their receptors in the common octopus (Octopus vul garis). Biochem J, 387: 85-91, 2005
    81. Kawada T, Kanda A, Minakata H, Matsushima O, Satake H. Identification of a novel receptor for an invertebrate oxytocin/vasopressin superfamily peptide: molecular and functional evolution of the oxytocin/vasopressin superfamily. Biochem J, 382: 231-237, 2004
    82. Iwakoshi-Ukena E, Ukena K, Takuwa-Kuroda K, Kanda A, Tsutsui K, Minakata H. Expression and distribution of octopus gonadotropin-releasing hormone in the central nervous system and peripheral organs of the octopus (Octopus vulgaris) by in situ hybridization and immunohistochemistry. J Comp Neurol, 477: 310-323, 2004
    83. Kanda A, Takuwa-Kuroda K, Iwakoshi-Ukena E, Furukawa Y, Matsushima O, Minakata H. Cloning of Octopus cephalotocin receptor, a member of the oxytocin/vasopressin superfamily. J Endocrinol, 179: 281-291, 2003
    84. Kanda A, Takuwa-Kuroda K, Iwakoshi-Ukena E, Minakata H. Single exon structures of the oxytocin/vasopressin superfamily peptides of octopus. Biochem Biophys Res Commun, 309: 743-748, 2003
    85. Takuwa-Kuroda K, Iwakoshi-Ukena E, Kanda A, Minakata H. Octopus, which owns the most advanced brain in invertebrates, has two members of vasopressin/oxytocin superfamily as in vertebrates. Regul Pept, 115: 139-149, 2003
    86. Kanda A, Iwakoshi-Ukena E, Takuwa-Kuroda K, Minakata H. Isolation and characterization of novel tachykinins from the posterior salivary gland of the common octopus Octopus vulgaris. Peptides, 24: 35-43, 2003